Page 572 - 先天性心脏病的导管术:从婴幼儿期到成人期
P. 572

554                                       先天性心脏病的导管术:从婴幼儿期到成人期



             参考文献

             [1]  Hascoet S, Dalla Pozza R, Bentham J, et al. Early outcomes of percutaneous pulmonary
                 valve implantation using the Edwards SAPIEN 3 transcatheter heart valve system. Eu-
                 roIntervention. 2019;14(13):1378-85.
             [2]  Holoshitz N, Hijazi ZM. Transcatheter pulmonary valve replacement: valves, techniques

                 of implantation and outcomes. Intervent Cardiol. 2013;4:465-77.
             [3]  Morray BH, McElhinney DB, Cheatham JP, Zahn EM, Berman DP, Sullivan PM, Lock
                 JE, Jones TK. Risk of coronary artery compression among patients referred for Tran-
                 scatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc In-

                 terv. 2013;6:535-42.
             [4]  Kenny D, Hijazi ZM, Kar S, et al. Percutaneous implantation of the Edwards SA-
                 PIEN transcatheter heart valve for conduit failure in the pulmonary position: early
                 phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol.

                 2011;58:2248-56.
             [5]  Kenny D, Rhodes J, Fleming G, et al. 3-year outcomes of the Edwards SAPIEN tran-
                 scatheter heart valve for conduit failure in the pulmonary position from the COMPAS-
                 SION multicenter clinical trial. JACC Cardiovasc Interv. 2018;11(19):1920-9.

             [6]  Haas NA, Moysich A, Neudorf U, et al. Percutaneous implantation of the Edwards
                 SAPIEN pulmonic valve: initial results in the first 22 patients. Clin Res Cardiol.
                 2013;102(2):119-28.
             [7]  Hascoet S, Dalla Pozza R, Bentham J, Carere RG, Kanaan M, Ewert P, Biernacka EK,

                 Kretschmar O, Deutsch C, Lecerf F, Lehner A, Kantzis M, Kurucova J, Thoenes M,
                 Bramlage P, Haas NA. Early outcomes of percutaneous pulmonary valve implanta-
                 tion using the Edwards SAPIEN 3 transcatheter heart valve system. EuroIntervention.
                 2019;14(13):1378-85.

             [8]  Plessis J, Hascoet S, Baruteau A, Godart F, Le Golan L, Warin Fresse K, Tahhan N,
                 Riou JY, Guyomarch B, Petit J, Guerin P. Edwards SAPIEN transcatheter pulmo-
                 nary valve implantation: results from a French registry. JACC Cardiovasc Interv.
                 2018;11(19):1909-16.

             [9]  Haas NA, Carere RG, Kretschmar O, Horlick E, Rodés-Cabau J, de Wolf D, Gewillig M,
                 Mullen M, Lehner A, Deutsch C, Bramlage P, Ewert P. Early outcomes of percutaneous
                 pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve
                 system. Int J Cardiol. 2018;250:86-91.
   567   568   569   570   571   572   573   574   575   576   577